Nektar Therapeutics (NKTR) financials · rev $55.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Nektar Therapeutics (NKTR) rev $55.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $55.2M | $98.4M |
| Cost of Revenue | N/A | $30.7M |
| Gross Profit | N/A | $67.7M |
| Operating Income | -$140.1M | -$105.2M |
| Net Income | -$164.1M | -$119.0M |
| EPS (Diluted) | -$9.73 | -$0.58 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $280.4M | $303.9M |
| Current Assets | $266.3M | $261.3M |
| Cash & Equivalents | $15.1M | $44.3M |
| Inventory | $0 | $0 |
| PP&E | $2.06M | $3.41M |
| Total Liabilities | $190.6M | $243.1M |
| Current Liabilities | $53.5M | $61.4M |
| Shareholders' Equity | $89.8M | $60.7M |
| Retained Earnings | -$3.76B | -$3.60B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$208.5M | -$175.7M |
| CapEx | $171.0K | $1.47M |
| Investing Cash Flow | -$1.20M | $142.6M |
| Financing Cash Flow | $180.6M | $42.1M |
| Net Change in Cash | -$29.1M | $8.97M |
| Free Cash Flow | -$208.7M | -$177.2M |
FAQ
What is NKTR P/E and revenue?
Nektar Therapeutics (NKTR) rev $55.2M.
What is NKTR revenue?
Nektar Therapeutics last cached revenue is $55.2M (FY2025).
Is NKTR profitable?
Nektar Therapeutics last cached net income is -$164.1M (FY2025).
What are NKTR total assets?
Nektar Therapeutics last cached total assets are $280.4M (FY2025).
What is NKTR free cash flow?
Nektar Therapeutics last cached free cash flow is -$208.7M (FY2025).
Not investment advice. Cached statements, not a live tape.